Prothena Corp. (PRTA) Misses Q4 EPS by 8c

Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($1.26), $0.08 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $316 million versus the consensus estimate of $2.15 million.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.

You May Also Be Interested In

• Citi turns more bullish on trucking stocks
• Novartis shares plunge 10% as failed drug trial clouds growth outlook
• QNB Corp. sells $254M in securities in portfolio repositioning